The establishment of the LifeArc Centre for Rare Mitochondrial Diseases marks a pivotal chapter in the pursuit of better diagnostics, treatments and hope for those affected by mitochondrial diseases. As the plans for the centre begin to fall into place, we’re thrilled to introduce an exclusive interview with one of the project leads, Professor Patrick Chinnery.

In this interview, Professor Chinnery tackles these pressing questions:

• Why does this investment matter so much, and why now?
• What does it mean for the future of mitochondrial disease research? How will the centre and its projects propel the mitochondrial disease field forward?
• Why is the role of patient organisations like The Lily Foundation important in projects like this?

The Lily Foundation’s role in shaping the future

The Lily Foundation is immensely proud to be a key partner in this transformative project, ensuring that the patient voice remains at the heart of this endeavour at all times.

As one of only four centres selected, this achievement highlights the credibility, expertise and dedication of all teams involved across the UK. It’s testament to the vision and shared commitment to transforming the landscape of mitochondrial disease care and research of everyone involved.

Tune in to this enlightening conversation with Professor Chinnery. It’s an opportunity to learn more about the ambitious goals of the LifeArc Centre and understand the pivotal role that partnerships like ours play in driving meaningful change.